Translational Development Acquisition (NASDAQ:TDACU) Stock Price Down 0.2% – What’s Next?

Translational Development Acquisition Corp. (NASDAQ:TDACU) shares dropped 0.2% during trading on Friday . The company traded as low as $10.44 and last traded at $10.44. Approximately 2,600 shares were traded during trading, a decline of 85% from the average daily volume of 17,917 shares. The stock had previously closed at $10.46.

Translational Development Acquisition Stock Down 0.2%

The firm has a 50 day moving average price of $10.45 and a two-hundred day moving average price of $10.44.

Institutional Trading of Translational Development Acquisition

A hedge fund recently bought a new stake in Translational Development Acquisition stock. Alberta Investment Management Corp acquired a new stake in shares of Translational Development Acquisition Corp. (NASDAQ:TDACU) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 600,000 shares of the company’s stock, valued at approximately $11,064,000.

About Translational Development Acquisition

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.